UAB

Foundation for Sarcoidosis Research and Walgreens Unite in Alabama to Boost Sarcoidosis Awareness and Spring Vaccine Education for April Awareness Month

Retrieved on: 
Monday, April 15, 2024
Education, Sarcoidosis, University, Inflammation, Pharmacy, Hospital, Blood, Respiratory syncytial virus, Death, Partnership, Research, Vaccine, Medicine, Bronchiolitis, Disease, Conditional sentence, Nervous system, University of Alabama, Patient, Immunodeficiency, UAB, Caregiver, Lung, Diagnosis, Infection, RSV, FSR, Pharmaceutical industry

CHICAGO, April 15, 2024 (GLOBE NEWSWIRE) -- Beginning April 15th, Walgreens, a pharmacy and retail leader who plays a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation’s medically underserved populations, and Foundation for Sarcoidosis Research (FSR), the leading international sarcoidosis organization, are proud to announce its renewed partnership to raise education and awareness about sarcoidosis and the importance of spring vaccinations with all Alabama-based Walgreens stores. As part of April’s Sarcoidosis Awareness Month from now through April 30th, all Walgreens stores in Alabama will join forces with FSR in an effort to spread awareness and support those affected by this chronic disease.

Key Points: 
  • As part of April’s Sarcoidosis Awareness Month from now through April 30th, all Walgreens stores in Alabama will join forces with FSR in an effort to spread awareness and support those affected by this chronic disease.
  • During this awareness campaign, Walgreens stores across Alabama will provide informational resources about sarcoidosis to their customers.
  • Every donation will directly support FSR’s initiatives to accelerate sarcoidosis research and provide crucial support to patients and their families.
  • FSR is proud to partner with Walgreens to raise awareness of the spring respiratory vaccines, which include RSV and Pneumonia.

Popular ArthritisPower® Patient Registry Expands Conditions and Becomes PatientSpot™

Retrieved on: 
Monday, April 15, 2024
Technology, FDA, Managed Care, Health, General Health, Health Technology, Medical Devices, Research, Apps, Applications, Artificial Intelligence, Science, Conditional sentence, Education, University, Patient, Psoriatic arthritis, Food, Spondyloarthropathy, Partnership, Human, Habit, Intelligence, Entrepreneurship, Arthritis, MPH, Rheumatoid arthritis, Medicine, UAB, Movement, RMD, Nursing

Patients can now join the registry and its community with any chronic condition they wish to share, establishing it as a truly disease-agnostic platform.

Key Points: 
  • Patients can now join the registry and its community with any chronic condition they wish to share, establishing it as a truly disease-agnostic platform.
  • Erik Stone, MA, Associate Director, Learning Experience Design at GHLF, explained, “Many of the patients we assist navigate multiple chronic conditions alongside arthritis.
  • It emerged as an innovative nationwide research registry, focusing on patients with rheumatic and musculoskeletal conditions (RMD), including rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis.
  • “We treasure the insights and experiences shared by patients dealing with arthritis and related conditions.

Digital Lending Market size to record USD 19.14 billion growth from 2023-2027, Rise in adoption of cloud-based digital lending servicing software offerings is one of the key market trends, Technavio

Retrieved on: 
Friday, April 19, 2024
Cloud, USD, MSME, Intercontinental Exchange, Intellect, Big data, Nucleus Software Exports, Internet, Blockchain, Abrigo, CoreLogic, Machine learning, First American Corporation, Artificial intelligence, CAPEX, Financial institution, Digital, Automation, App Store (iOS/iPadOS), Privacy, Computer security, UAB, Fiserv, Telecom, Organization, Growth, Temenos AG, OPEX

The digital lending market is experiencing rapid growth due to cloud-based loan servicing.

Key Points: 
  • The digital lending market is experiencing rapid growth due to cloud-based loan servicing.
  • In the rapidly evolving digital lending market, financial security is a top priority.
  • In the Digital Lending Market, financial institutions leverage technology to process loan applications, assess creditworthiness, and disburse loans digitally.
  • Digital Lending Market  is fragmented ; the companies are competing with competitors and are trying to get greater market share.

Acclaimed Clinical Geneticist Dr. Bruce Korf Honored with 2024 David L. Rimoin Lifetime Achievement Award in Medical Genetics from the ACMG Foundation for Genetic and Genomic Medicine

Retrieved on: 
Wednesday, March 13, 2024
Department of Defence, Friends, Patient, Medical genetics, Travel, Child, Neurofibromatosis, Practice, UAB, Gene expression, Dean (education), Education, Rockefeller University, Seed, NF, NIH, American College, Pediatrics, Person, Karyotype, MD–PhD, Boston Children's Hospital, Principle, Birmingham School of Law, Neurology, FACOG, Genetics, Cornell University, American Journal, Research, Hospital, University, Human genetics, Student, Publication, DRS, ACMG, Book, Genetic distance, DSM-IV codes, Diagnosis, FACMG, Empathy, Montefiore Medical Center, Distinguishing, Mouse, Hope, Doctor of Philosophy, Life, Genetic, Bangladesh Technical Education Board, Physician, Nursing

BETHESDA, Md., March 13, 2024 /PRNewswire/ -- Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.

Key Points: 
  • BETHESDA, Md., March 13, 2024 /PRNewswire/ -- Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.
  • Dr. Korf is an authentic, kind and ethical human being whose life and career in medical genetics are unparalleled."
  • "Dr. Korf's extraordinary accomplishments in clinical genetics, neurofibromatosis, and genomics, as well as his dedication to education make him a well deserving winner of the David Rimoin Lifetime Achievement Award.
  • Before he died, David appreciated the opportunity to work with Bruce first-hand in the editing of Principles and Practice of Medical Genetics as well as on numerous committees for the ACMG.

DC BLOX Expands Birmingham Data Center to Empower High-Performance Computing

Retrieved on: 
Thursday, March 7, 2024
Commercial Building & Real Estate, Apps, Applications, Technology, Construction & Property, Software, Networks, Hardware, Data Management, Artificial Intelligence, HPC, AVP, Research, Biotechnology, Testament, Artificial intelligence, University, Government, Economic development, COVID-19, GPU, Machine learning, UAB, Heart, Graphics processing unit, Renewable energy

DC BLOX , a premier provider of secure and reliable data centers and fiber network solutions throughout the Southeast, today announced the completed expansion of its Birmingham, Alabama data center .

Key Points: 
  • DC BLOX , a premier provider of secure and reliable data centers and fiber network solutions throughout the Southeast, today announced the completed expansion of its Birmingham, Alabama data center .
  • The new data hall design signifies a major advancement in DC BLOX’s mission to deliver cutting-edge solutions that empower local businesses, government entities, and academic institutions.
  • “This expansion underscores DC BLOX’s steadfast dedication to empowering the technology-based economy of Birmingham and beyond,” said Jeff Uphues, CEO of DC BLOX .
  • For more information on DC BLOX and our expanded Birmingham data hall, please visit https://www.dcblox.com .

ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS

Retrieved on: 
Monday, March 4, 2024
CFO, Acquisition, Ageing, ICREA, LEAS, Memory, Patent, Cognition, UAB

NEW YORK, March 4, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases.

Key Points: 
  • NEW YORK, March 4, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases.
  • Dr. Joseph Sinkule, the Founder and CEO of ANEW stated "Obtaining a patent in China was difficult but important to our global product development programs in neurodegenerative diseases.
  • The aging population in China is affected by the same age-related diseases we are fighting in the US and Europe.
  • In May 2023, ANEW announced its proposed merger with a special purpose acquisition company ("SPAC") called Redwoods (NASDAQ: RWOD) ("RWOD" or "Redwoods").

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Retrieved on: 
Monday, January 8, 2024
Oncology, Health, Stem Cells, Neurology, Research, Science, Biotechnology, Virus, Cell, Cancer, Distinguishing, University, Biologic, Dove Medical Press, Neuroscience, UAB Hospital, Emory University, National academy, UAB, Glioblastoma, Radiation therapy, Neuro, Nature Biotechnology, Physician, Birmingham School of Law, Engineering, Neurosurgery, Potyvirus, Harvard Medical School, Supernova, Pulmonology, Hospital, Bangladesh Technical Education Board, University of Groningen, PNAS, Pharmaceutical industry

Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies today announced the appointment of three new members to its Scientific and Medical Advisory Board.

Key Points: 
  • Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies today announced the appointment of three new members to its Scientific and Medical Advisory Board.
  • “Calidi continues to expand our Scientific and Medical Advisory Board, adding leading physicians and scientists from the top cancer hospitals and research institutions in the United States,” said Allan Camaisa, CEO and Chairman of the Board of Calidi Biotherapeutics.
  • Dr. Chiocca is a faculty member at Harvard Medical School and leads a laboratory focused on developing novel genetic therapies for malignant brain tumors.
  • from the University of Tennessee and completed his residency and fellowship at UAB Hospital in Neurology and Neuro-oncology.

Commercial Refrigeration Equipment Market size to increase by USD 14.50 billion during 2022-2027, The need to increase the storage life of food products to drive the growth - Technavio

Retrieved on: 
Friday, January 5, 2024
Refrigerator, AIR, Refrigeration, Electrolux, Middleby Corporation, Glass, Dover Corporation, Certification, Supermarket, Catering, USD, UAB, YOY, Sample, Temperature, Free, Lennox International, Daikin, Growth, Transport, Nature

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The commercial refrigeration equipment market size is expected to grow by USD 14.50 billion between 2022 and 2027.

Key Points: 
  • NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The commercial refrigeration equipment market size is expected to grow by USD 14.50 billion between 2022 and 2027.
  • The need to increase the storage life of food products is a key factor driving market growth.
  • The inadequate temperature during storage can lead to degradation and losses, particularly in commercial spaces like food service establishments.
  • For example, commercial refrigeration equipment with ENERGY STAR certification is 20% more energy efficient compared to standard commercial refrigeration equipment.

Guideway Care Lauds CMS New Payment Policies for Reimbursing Navigation Services Advancing Health Equity, Partners with Hospitals, Health Systems, Physician Practices to Capture New Revenue Opportunities

Retrieved on: 
Tuesday, November 14, 2023
Software, Managed Care, Networks, Oncology, Data Management, Payments, Technology, Infectious Diseases, Hospitals, Practice Management, Health, Diabetes, Social, Health equity, Acquisition, Organization, Patient satisfaction, Care, PIN, CPT, CMMI, Patient, JAMA Oncology, UAB, Birmingham School of Law, Social determinants of health, CMS, University, MD, Patient Activation Measure, NORC, Medicare, Hospital, Parker, Nursing, Pharmaceutical industry, Automated guideway transit

In 2017, Dr. Partridge and his team from UAB published their groundbreaking results in JAMA Oncology .

Key Points: 
  • In 2017, Dr. Partridge and his team from UAB published their groundbreaking results in JAMA Oncology .
  • The article articulated the finding that lay navigators in oncology were highly effective at addressing patients’ underlying social determinants, which negatively impact their health and increase healthcare costs.
  • For a full summary of what the new CMS rule means for patients, providers and the healthcare system, click here .
  • “The challenge for healthcare providers is that taking advantage of the new revenue opportunities will require carefully trained care navigators with structured workflows and new documentation systems,” continued Parker.

NCCN Summit Navigates Solutions for Financial and Other Cancer-Related Hardships

Retrieved on: 
Tuesday, December 5, 2023
Disease, Health equity, Cancer Support Community, Senior, DNP, Life, Patient, UAB, CMS, Partnership, Doctor of Philosophy, Mental health, Quality of life, Engagement, Toxicity, National Comprehensive Cancer Network, Mortality, MSS, MSCE, Risk, CSSBB, Health, FCPP, DEI, Estate (law), Durrow healthcare consultancy, Public policy, FACP, NCCN, University of Pennsylvania, Imerman Angels, Social conditioning, ACCC, Leadership Council, Patient navigators, University, Medicare, Diversity, Education, Chief innovation officer, Associate, LCSW, Policy, MMM, Navigation, RN, Breast cancer, LSW, Inclusion, Refugee, Survival, Social work, Wastewater treatment, Pharmaceutical industry, Medical device, Hospital, Management, Nursing, Cancer, MSW, Medicine, MD

PLYMOUTH MEETING, Pa., Dec. 5, 2023 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted a Patient Advocacy Summit to explore the role of navigation throughout the cancer process. A diverse group of subject matter experts addressed the impact patient navigation has on care and how to utilize navigators to reduce economic burdens and disparities in care. The speakers included patients and advocates, policymakers, health care providers, and health data analysts.

Key Points: 
  • Denlinger
    The summit featured a series of best practice presentations highlighting some of the tools available to assist in various areas of patient navigation.
  • Speakers identified significant financial hardships that can come with cancer care, which can contribute to logistical barriers or issues involving emotional well-being.
  • Navigating a patient through their healthcare coverage and preventing financial ruin from astronomical cancer care costs has grown more complex.
  • NCCN's annual Patient Advocacy Summit follows another recent Oncology Policy Summit where the organization unveiled recommendations for screening health-related social needs ( HRSN ) in cancer care.